Open AccessSodium Glucose Transporter 2 (SGLT2) Inhibition does not Protect the Myocardium from Acute Ischemic Reperfusion Injury but Modulates Post- Ischemic Mitochondrial Function
Author(s) -
Jespersen Nr,
Lassen Tr,
Hjortbak Mv,
Støttrup Nb,
Hans Erik Bøtker
Publication year - 2017
Publication title -
cardiovascular pharmacology: open access
Language(s) - English
Resource type - Journals
ISSN - 2329-6607
DOI - 10.4172/2329-6607.1000210
Subject(s) - empagliflozin , cardioprotection , ischemic preconditioning , ischemia , medicine , respiration , cardiology , myocardial infarction , anesthesia , pharmacology , diabetes mellitus , endocrinology , type 2 diabetes , anatomy